6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2022-08-17), PDL BioPharma's 6-1 Month Momentum % is -4.86%.
The industry rank for PDL BioPharma's 6-1 Month Momentum % or its related term are showing as below:
PDLI's 6-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -23.53
vs PDLI: -4.86
Competitive Comparison
For the Biotechnology subindustry, PDL BioPharma's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PDL BioPharma 6-1 Month Momentum % Distribution
For the Biotechnology industry and Healthcare sector, PDL BioPharma's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where PDL BioPharma's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
PDL BioPharma 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of PDL BioPharma's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
PDL BioPharma Inc acquires and manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. The operating segments of the company are Medical Devices, Strategic Positions, Pharmaceutical and Income Generating Assets, of which key revenue is derived from the Pharmaceutical segment. The Pharmaceutical segment consists of revenue derived from branded prescription medicine products sold under the name Tekturna and Tekturna HCT in the U.S, and Rasilez and Rasilez HCT in the rest of the world (collectively, the Noden Products). Geographically, the company operates in Europe, North America, Asia and Other countries, of which prime revenue is generated from Asia and North America.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0(0%) 9:40AM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:PDLI has been successfully added to your 
